364 related articles for article (PubMed ID: 10816596)
1. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.
Lundin L; Larsson H; Kreuger J; Kanda S; Lindahl U; Salmivirta M; Claesson-Welsh L
J Biol Chem; 2000 Aug; 275(32):24653-60. PubMed ID: 10816596
[TBL] [Abstract][Full Text] [Related]
2. Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.
Rusnati M; Coltrini D; Caccia P; Dell'Era P; Zoppetti G; Oreste P; Valsasina B; Presta M
Biochem Biophys Res Commun; 1994 Aug; 203(1):450-8. PubMed ID: 8074689
[TBL] [Abstract][Full Text] [Related]
3. Differential tyrosine phosphorylation of fibroblast growth factor (FGF) receptor-1 and receptor proximal signal transduction in response to FGF-2 and heparin.
Lundin L; Rönnstrand L; Cross M; Hellberg C; Lindahl U; Claesson-Welsh L
Exp Cell Res; 2003 Jul; 287(1):190-8. PubMed ID: 12799194
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
Ashikari-Hada S; Habuchi H; Sugaya N; Kobayashi T; Kimata K
Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
Millette E; Rauch BH; Defawe O; Kenagy RD; Daum G; Clowes AW
Circ Res; 2005 Feb; 96(2):172-9. PubMed ID: 15625285
[TBL] [Abstract][Full Text] [Related]
6. Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds.
Liekens S; Leali D; Neyts J; Esnouf R; Rusnati M; Dell'Era P; Maudgal PC; De Clercq E; Presta M
Mol Pharmacol; 1999 Jul; 56(1):204-13. PubMed ID: 10385702
[TBL] [Abstract][Full Text] [Related]
7. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin.
Sasaki T; Larsson H; Kreuger J; Salmivirta M; Claesson-Welsh L; Lindahl U; Hohenester E; Timpl R
EMBO J; 1999 Nov; 18(22):6240-8. PubMed ID: 10562536
[TBL] [Abstract][Full Text] [Related]
8. Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells.
Kornmann M; Lopez ME; Beger HG; Korc M
Int J Pancreatol; 2001; 29(2):85-92. PubMed ID: 11876253
[TBL] [Abstract][Full Text] [Related]
9. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes.
Ostrovsky O; Berman B; Gallagher J; Mulloy B; Fernig DG; Delehedde M; Ron D
J Biol Chem; 2002 Jan; 277(4):2444-53. PubMed ID: 11714710
[TBL] [Abstract][Full Text] [Related]
12. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization.
Perollet C; Han ZC; Savona C; Caen JP; Bikfalvi A
Blood; 1998 May; 91(9):3289-99. PubMed ID: 9558385
[TBL] [Abstract][Full Text] [Related]
13. Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes.
Zhang F; Zhang Z; Lin X; Beenken A; Eliseenkova AV; Mohammadi M; Linhardt RJ
Biochemistry; 2009 Sep; 48(35):8379-86. PubMed ID: 19591432
[TBL] [Abstract][Full Text] [Related]
14. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
15. Heparin can activate a receptor tyrosine kinase.
Gao G; Goldfarb M
EMBO J; 1995 May; 14(10):2183-90. PubMed ID: 7774576
[TBL] [Abstract][Full Text] [Related]
16. A dimeric ternary complex of FGFR [correction of FGFR1], heparin and FGF-1 leads to an 'electrostatic sandwich' model for heparin binding.
Huhtala MT; Pentikäinen OT; Johnson MS
Structure; 1999 Jun; 7(6):699-709. PubMed ID: 10404599
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-2 can mediate cell attachment by linking receptors and heparan sulfate proteoglycans on neighboring cells.
Richard C; Liuzzo JP; Moscatelli D
J Biol Chem; 1995 Oct; 270(41):24188-96. PubMed ID: 7592623
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1.
Berry D; Shriver Z; Natke B; Kwan CP; Venkataraman G; Sasisekharan R
Biochem J; 2003 Jul; 373(Pt 1):241-9. PubMed ID: 12659634
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
McKeehan WL; Kan M
Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
[TBL] [Abstract][Full Text] [Related]
20. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
